MLAB
Mesa Laboratories, Inc.
NASDAQ · USTechnologyHardware, Equipment & Parts
$96.67-1.30%
Price as of Jul 20, 2026
MLAB financials
Mesa Laboratories, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $249.1M | $241.0M | $216.2M | $219.1M |
| Cost of revenue | $90.9M | $90.1M | $82.9M | $85.4M |
| Gross profit | $158.3M | $150.9M | $133.3M | $133.7M |
| Operating expenses | $139.8M | $134.5M | $405.3M | $130.4M |
| Operating income | $18.5M | $16.3M | -$272.1M | $3.3M |
| Net income | $6.7M | -$2.0M | -$254.2M | $930.0K |
| EBITDA | $35.3M | $42.3M | -$238.4M | $37.5M |
| Basic EPS | $1.22 | $-0.36 | $-47.20 | $0.17 |
| Diluted EPS | $1.21 | $-0.36 | $-47.20 | $0.17 |
| Balance sheet | ||||
| Cash & equivalents | $26.9M | $27.3M | $28.2M | $32.9M |
| Total assets | $427.7M | $433.3M | $446.8M | $661.8M |
| Total liabilities | $241.5M | $273.5M | $301.4M | $268.4M |
| Stockholders’ equity | $186.2M | $159.8M | $145.4M | $393.5M |
| Total debt | $168.8M | $181.5M | $231.3M | $186.1M |
| Net debt | $141.9M | $154.2M | $203.1M | $153.2M |
| Cash flow | ||||
| Operating cash flow | $42.8M | $46.8M | $44.1M | $28.0M |
| Capital expenditure | -$3.3M | -$4.5M | -$2.6M | -$4.5M |
| Free cash flow | $39.6M | $42.3M | $41.6M | $23.4M |
| Dividends paid | -$3.5M | -$3.5M | -$3.4M | -$3.4M |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |